The monoclonal antibody Itolizumab received authorization to start a phase III clinical trial in Covid-19 patients in the US, Mexico and Brazil
Posted in Inglés

New joint venture created in Mariel to distribute biotechnology products

biotechnology products- The Cuban enterprise Cimab S.A. and Neuronic Mexicana S.A. establish a new company named IncuBIO

Seguir leyendo